Cases 51 - 60 of 101
Bayer Intellectual Property GmbH et al v. Lupin Limited et al
as 1:2017cv01047
Plaintiff:
Bayer Intellectual Property GmbH , Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Lupin Limited and Lupin Pharmaceuticals, Inc.
Counter_claimant:
Lupin Limited and Lupin Pharmaceuticals, Inc.
Counter_defendant:
Bayer AG , Bayer Intellectual Property GmbH and Janssen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Mitsubishi Tanabe Pharma Corp. et al v. Teva Pharmaceuticals USA, Inc.
as 1:2017cv00998
Plaintiff:
Mitsubishi Tanabe Pharma Corp. , Janssen Pharmaceuticals, Inc. , Janssen Pharmaceutica NV and others
Defendant:
Teva Pharmaceuticals USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Mitsubishi Tanabe Pharma Corporation et al v. Apotex Inc. et al
as 1:2017cv00990
Plaintiff:
Mitsubishi Tanabe Pharma Corporation , Janssen Pharmaceuticals Inc. , Janssen Pharmaceutica, N.V. and others
Defendant:
Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 271
Bayer Intellectual Property GMBH et al v. InvaGen Pharmaceuticals, Inc.
as 1:2017cv00812
Plaintiff:
Bayer Intellectual Property GMBH , Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
InvaGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Bayer Intellectual Property GmbH et al v. Alembic Pharmaceuticals Limited et al
as 1:2017cv00675
Plaintiff:
Bayer Intellectual Property GmbH , Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Alembic Pharmaceuticals Limited, Alembic Global Holding SA and Alembic Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Bayer Intellectual Property GmbH et al v. Sigmapharm Laboratories, LLC
as 1:2017cv00648
Plaintiff:
Bayer Intellectual Property GmbH , Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Sigmapharm Laboratories, LLC
Counter_claimant:
Sigmapharm Laboratories, LLC
Counter_defendant:
Bayer AG , Bayer Intellectual Property GmbH and Janssen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Bayer Intellectual Property GmbH et al v. Mylan Pharmaceuticals Inc.
as 1:2017cv00584
Plaintiff:
Bayer Intellectual Property GmbH , Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Bayer Intellectual Property GmbH et al v. Micro Labs Ltd. et al
as 1:2017cv00560
Plaintiff:
Bayer Intellectual Property GmbH , Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Micro Labs Ltd. and Micro Labs USA Inc.
Cause Of Action: 35 U.S.C. § 271
Bayer Intellectual Property GMBH et al v. Aurobindo Pharma Limited et al
as 1:2017cv00483
Plaintiff:
Bayer Intellectual Property GMBH , Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al
as 1:2017cv00462
Plaintiff:
Bayer Intellectual Property GMBH , Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
